Denied Tecentriq (atezolizumab) by UnitedHealthcare in Illinois? Complete Appeal Guide (2025 Forms & Timelines)
Answer Box: Getting Tecentriq (atezolizumab) Covered by UnitedHealthcare in Illinois
Fastest path to approval: Submit prior authorization through UnitedHealthcare's provider portal with oncologist specialty, PD-L1 test results (≥50% tumor cells or ≥10% immune cells for NSCLC), and NCCN guideline support. If denied, request peer-to-peer review within 180 days—